Literature DB >> 32767458

Cosmetic outcomes following transoral versus transcervical thyroidectomy.

Lena W Chen1, Christopher R Razavi1, Hanna Hong1, Akeweh Fondong1, Rohit Ranganath1, Surya Khatri1, Wojciech K Mydlarz2, Aarti Mathur3, Masaru Ishii4, Jason Nellis2, Mohammad Shaear1, Ralph P Tufano1, Jonathon O Russell1.   

Abstract

BACKGROUND: Central neck scars following thyroidectomy can negatively impact patient quality of life. Transoral endoscopic thyroidectomy can reduce postoperative cosmetic burden.
METHODS: Prospective cohort study of patients seen between June 2018 and January 2019. Scar cosmesis was determined using the validated Scar Cosmesis Assessment and Rating (SCAR) scale and a Visual Analog Scale (VAS) measuring color, contour, and irregularity.
RESULTS: Eighty-one patients (80% female, mean age 43.7 years) were analyzed, with 60% and 40% receiving transcervical and transoral thyroidectomy. Median time from surgery was 3.4 (range: 1-37.1) weeks. Mean SCAR score was greater for transcervical recipients (4.69 vs transoral 0.99, P < .001), indicating worse cosmesis. Mean surgeon-rated total VAS score was similarly increased for transcervical recipients (72.84 vs transoral 16.73, P < .001). Interrater reliability for both SCAR and total VAS scores was excellent (intraclass correlation 0.93; 95% CI: 0.90-0.95 for both).
CONCLUSION: Transoral thyroidectomy provides significantly enhanced early cosmesis over the transcervical approach.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  scar cosmesis; scarless; thyroidectomy; transcervical; transoral

Mesh:

Year:  2020        PMID: 32767458     DOI: 10.1002/hed.26383

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Transoral Tongue Suspension for Obstructive Sleep Apnea-A Preliminary Study.

Authors:  Li-Jen Hsin; Yi-Chan Lee; Wan-Ni Lin; Yi-An Lu; Li-Ang Lee; Ming-Shao Tsai; Wen-Nuan Cheng; Yen-Ting Chiang; Hsueh-Yu Li
Journal:  J Clin Med       Date:  2022-08-24       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.